Powder: -20℃ for 3 years. In solvent: -80℃ for 1 year.
Description
Cabozantinib S-malate (XL184) is the s-malate salt form of cabozantinib, an orally bioavailable, small molecule receptor tyrosine kinase (RTK) inhibitor with potential antineoplastic activity.